Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.2 to v3.5.3, representing a small update to the page metadata. No substantive study information appears to have changed.
    Difference
    0.0%
    Check dated 2026-04-30T15:38:49.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2; no visible changes to the study details are apparent.
    Difference
    0.0%
    Check dated 2026-04-16T10:27:22.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Added 2026-04-01 and 2027-02-25; removed 2027-02-18 and 2026-02-19 from the Study Record Dates section.
    Difference
    0.1%
    Check dated 2026-04-02T00:21:34.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision history updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-25T20:38:33.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Added the disease tag 'Malignant pleural mesothelioma' and included the Genetic and Rare Diseases Information Center as a resource; several older update dates were removed.
    Difference
    0.3%
    Check dated 2026-03-18T15:01:24.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. There are no user-visible changes to the study details or layout.
    Difference
    0.0%
    Check dated 2026-03-11T14:44:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.